MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04327cam a2200625 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn899279901 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221128212825.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
140923s2015 nyu ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2020687203 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| 019 ## - |
|---|
| -- |
914151426 |
| -- |
923677268 |
| -- |
928196480 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9781634632461 |
| Qualifying information |
ebook |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
163463246X |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781634632270 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
1634632273 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
940572 |
| -- |
(N$T) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)899279901 |
| Canceled/invalid control number |
(OCoLC)914151426 |
| -- |
(OCoLC)923677268 |
| -- |
(OCoLC)928196480 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WH 170 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
HEA |
| Subject category code subdivision |
039000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
014000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
022000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
112000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
045000 |
| Source |
bisacsh |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Hemolytic uremic syndrome : |
| Subtitle |
symptoms, treatment options, and prognosis |
| Statement of responsibility, etc |
|
| Medium |
[E-Book] |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Nova Biomedical, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2015] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES TITLE |
|---|
| Series statement |
Renal and urologic disorders |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - CONTENTS |
|---|
| Contents |
Chapter I: The Role of Thrombin in Hemolytic Uremic Syndrome and Other Thrombotic Microangiopathies; Abstract; Introduction; 1. Thrombin Activation in EndothelialCell Physiology; 2. Modulation of Thrombin in TMAs; 3. Effects of Shiga Toxin on EndothelialCells and Thrombin Production; 4. Animal Models; 5. Treatments Targeting Thrombin in HUSand TMAs. |
| 505 8# - CONTENTS |
|---|
| Contents |
6. Inflammation and Thrombosis:Connections and ConvergenceConclusion; References -- Chapter II: Therapeutic Apheresis in Children with Renal Diseases, Especially Hemolytic Uremic Syndrome; Abstract; Introduction; Hemolytic-Uremic Syndrome (HUS); Rapidly Progressive Glomerulonephritis (RPGN); Anti-Basement Membrane Antibody Glomerulonephritis (Goodpasture Syndrome, ABM-ab-GN); Immune Complex Nephritis (ICN); RPGN with or without Glomerular Deposition (ANCA ab) Pauci-Immune RPGN; Therapy Recommendations for RPGN; Glomerulonephritis with Nephrotic Syndrome (NS); Myoglobulinemic Renal Failure. |
| 505 8# - CONTENTS |
|---|
| Contents |
Acute Kidney Injury (AKI)Kidney Transplant Rejection; Summary; References -- Chapter III: The Consequences of Soliris�Therapy in Patients with aHUS; Abstract; Background; The Role of Complement in aHUS; Limitations of Supportive Care Options; Eculizumab; Treatment; Ethical Annotation; Conclusion; References -- Chapter IV: Hemolytic Uremic Syndrome: Overview and Update; Abstract; HUS is Classified Accordingto the Etiology into 3 Categories; Epidemiology; Symptoms; Extrarenal Complications; Pathogenesis; Diagnosis; Treatment Options; Prognosis; Conclusion; References; Blank Page; Index. |
| 520 ## - ABSTRACT |
|---|
| Abstract |
Hemolytic uremic syndrome (HUS) is characterized by the triad non-immune micro-angiopathic hemolytic anemia, thrombocytopenia and acute renal failure. The disease mainly affects children one to ten years of age. It begins after an incubation period of 4 to 7 days with abrupt onset of bloody diarrhea and abdominal pain. Two to ten days later, microangiopathy, haemolytic anaemia, thrombocytopenia, and acute renal failure develop. HUS microangiopathy can involve almost any organ, but damage to kidneys and central nervous system cause the most severe clinical problems. This book discusses the symp. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Master record variable field(s) change: 050, 082 |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Hemolytic-uremic syndrome. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Kidneys |
| General subdivision |
Diseases. |
| 650 12 - SUBJECT HEADINGS |
|---|
| Subject term |
Hemolytic-Uremic Syndrome. |
| 650 22 - SUBJECT HEADINGS |
|---|
| Subject term |
Kidney Diseases. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Clayton, Glenna, |
| Relator term |
editor. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Renal and urologic disorders. |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=940572">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=940572</a> |
| Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record. |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
12092714 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
940572 |
| 938 ## - |
|---|
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10997880 |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL2084866 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
N$T |